OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025 MIAMI, April 17, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2025 after the close of the U.S. financial markets on Wednesday, April 30, 2025. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on April 30th beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to p...
A director at FB Financial Corp bought 7,200 shares at 40.490USD and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
Axalta Wins 2025 Automotive News PACE Pilot Award Axalta NextJet™ automotive digital paint technology named Innovation to Watch PHILADELPHIA, April 16, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems (AXTA), a leading global coatings company, announced today that the digital paint technology Axalta NextJet™ was named a 2025 Automotive News PACE Pilot Innovation to Watch. The recognition honors pre-commercial innovations in the automotive and future mobility space. is a next-generation, sustainable digital paint technology for the automotive industry. This advancement allows for precis...
Axalta Schedules First Quarter 2025 Earnings Conference Call PHILADELPHIA, April 09, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems (NYSE: AXTA), a leading global coatings company, will release its first quarter 2025 financial results at 6 a.m. ET on Wednesday, May 7. The release and supporting materials will be posted to . In addition, the company will host a conference call at 8 a.m. ET on May 7. Chris Villavarayan, Chief Executive Officer and President, and Carl Anderson, Senior Vice President and Chief Financial Officer, will review the company's financial performance for the period...
Axalta Takes Home Two Prestigious Edison Awards™ Axalta Irus Scan™ and MyColor recognized among most innovative new products in the world PHILADELPHIA, April 07, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems (AXTA), a leading global coatings company, announced that it has won two 2025 Edison Awards™. won Silver in the Automotive Materials category and won Bronze in the Automotive Materials category. This is the seventh consecutive year that Axalta has earned coveted Edison Awards which honor market-leading innovations of new products and services. “Innovation is core to what we d...
OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized an increase of $100 million to the Company’s existing common stock repurchase program, bringing the aggregate capacity of the program to $200 million. Approximately $41 million of OPKO’s common stock has been repurchased under the existing program since its authorization in July 2024. “We believe OPKO’s shares continue to be significantly undervalued and offer an attractive...
A director at Opko Health Inc bought 200,000 shares at 1.739USD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders MIAMI and JERUSALEM, March 17, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, entered into a collaboration and license agreement to advance into the clinic the first oral dual agonist GLP-1/glucagon peptide as a once-daily tablet treatment for patients with obesity, metabolic and fibrotic disorders. ...
Two Directors at Marriott Vacations Worldwide Corp bought 5,650 shares at between 71.660USD and 72.040USD. The significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.